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  Mycoplasma ovipneumoniae is considered as an important pathogen of small 
ruminants, but its antigenic proteins are not well known so far. In this study, we 
cloned the EF-Tu gene of M. ovipneumoniae and analyzed the molecular features of 
the gene and its coding protein for the first time. The gene was then expressed in 
E.coli and the antigenicity of the coding protein was evaluated as well. The EF-Tu 
gene of M. ovipneumoniae is 1209 bp in length, encodes 402 amino acids, and 
shares the highest DNA sequence identity of 87.5% and deduced amino acid 
sequence identity of 97.8% with those of M. hyopneumoniae, respectively. The 
recombinant EF-Tu protein can react with the polyclonal antiserum of M. 
ovipneumoniae and can induce humoral immune responses in mice, which indicated 
that the EF-Tu may be used as a candidate protein in developing the technologies to 
control the disease. 
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INTRODUCTION 
 
Mycoplasma ovipneumoniae, belongs to the 
Mycoplasmaceae, is considered to be a cause of non-
progressive pneumonia of both sheep and goats (Niang et 
al., 1998; Besser et al., 2008). As well as causing disease 
in its own right, M. ovipenumoniae predisposes animals to 
invasion by more serious respiratory pathogens, such as 
Mannheimia haemolytica, Pasteurlla and Parainfluenza 3 
virus  (Dassanayake  et al., 2010). Compared to other 
pathogenic mycoplasmas, less attention of research has 
been paid on M. ovipneumoniae, which could 
substantially impede understanding of the pathogenesis 
and developing technologies for control of M. 
ovipneumoniae infection.  
Elongation factor (EF) is a major translational factor, 
which catalyzes the binding of aminoacyl-tRNA to the A-
site of the ribosome (Andaleeb et al., 2011). It is not only 
a protein necessary for translation but also one of the most 
important multifunctional proteins. EF has been shown to 
be involved in various important cellular processes or 
diseases, including signal transduction, translational 
control, apoptosis, cytoskeletal organization, virus 
replication and oncogenic transformation (Zhou et al., 
2007). Besides, EF-Tu can also provide beneficial effects 
against enteropathogen infection in vitro (Akhilesh et al., 
2011). Elongation factor Tu (EF-Tu) of M. 
hyopneumoniae  had already been identified as an 
antigenic protein (Pinto et al., 2007). Comparative 
analysis of known genomic sequences suggested that M. 
ovipneumoniae and M. hyopneumoniae share high 
homology, indicating that the two species of mycoplasma 
may exhibit similar mechanisms of active phenotypic 
switch and antigenic variation (Minion et al., 2004). The 
recent published un-annotated draft genomic sequences of 
M. ovipneumniae strain SC01 encouraged us to take the 
present study to evaluate if EF-Tu of M. ovipneumoniae is 
also an antigenic protein for potential use of disease 
control.  
 
MATERIALS AND METHODS 
 
Bacteria and sera: M. ovipneumoniae strain GH3-3 was 
an isolate from sheep in Gansu province, China (Xu et al., 
2011). Polyclonal antiserum of M. ovipneumoniae was 
prepared as described before (Zhou et al., 2009).  
 
Clone and synthesis of EF-Tu gene: EF-Tu gene 
sequence of M. ovipneumoniae was searched out from the 
draft genome of M. ovipneumoniae strain SC01 based on 
the EF-Tu gene sequence of the M. hyopneumoniae 232 
strain (AE017332.1) using the MegAlign program of 
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Lasergene software version 7.1 (Madison, Wisconsin 
USA). The following primers, designed according to the 
EF-Tu gene sequence of SC01, were used to amplify EF-
Tu gene of strain GH3-3: forward 5’-
ATGGCAGTTGTTAAAACG-3’; reverse 5’-
TTATTTAATAATTTCGGT-3’. The amplified product 
was purified and cloned into the pMD18-T vector (Takara 
Co., ltd., Dalian China) for sequencing. Then the EF-Tu 
gene  sequence of M. ovipneumoniae strain GH3-3 was 
compared with that of strain SC01, and was optimized as 
follows to express in E. coli: (1) All TGA codons were 
changed into TGG; (2) Xho  I and Noc  I restriction 
enzymes cut sites were added at 3’ and 5’-end, 
respectively; (3) Other optimization to improve the 
productiveness in E.coli  BL21 (DE3) were made. The 
original and optimized EF-Tu gene sequences of  strain 
GH3-3 were given in Fig. 1. The optimized EF-Tu gene 
was synthesized and cloned into the plasmid pUC57-
simple in GenScript Co., Ltd. (Nanjing, China). 
 
Molecular features of the EF-Tu gene and protein: The 
EF-Tu gene and protein sequences of 11 known 
Mycoplasma  species collected from BLAST program 
(http://www.ncbi.nlm.nih.gov/blast) were used to compare 
with  M.  ovipneumoniae strain GH3-3 using MegAlign 
program. The primary structure of the EF-Tu protein, 
including physical and chemical property, and trans-
membrane domain, was predicted using ExPASy software 
tools (http://www.expasy.ch/tools/#primary). The 
prediction of protein secondary structure, including α-
helix,  β-sheet, turn and coil, flexibility, hydrophilicity, 
antigenic index, and surface probability, was scored using 
Protean program of Lasergene software version 7.1. The 
signal peptide of the protein was predicted by SignalP 4.0 
Server (http://www.cbs.dtu.dk/services/SignalP/). The 
potential antigen epitopes were predicted using 
DNAMAN software (Lynnon Biosoft, USA).  
 
Expression, purification and Western blotting of 
recombinant EF-Tu: The synthesized EF-Tu gene was 
sub-cloned into plasmid pET32a (Invitrogen, USA) and 
was then transformed into E.coli BL21 (DE3) (TranGen 
Biotech Co., ltd., Beijing China) by using regular heat-
shock transformation method. A single positive clone was 
picked into 10 ml of Luria-Bertani (LB) broth and 
cultured at 37°C. Isopropyl β-D-1-Thiogalactopyrano- 
side (IPTG) was added at a final concentration of 0.5 mM 
for preliminary induction to express when the OD600 of the 
culture reached 0.4. After an additional 8 h of cultivation, 
the culture broth was centrifuged at 1200x g for 1 min. 
The harvested cells were suspended in pH 7.2 Phosphate 
Buffered Saline (PBS) and three times volume of protein 
loading buffer (4×) (Takara Co., ltd., Dalian China) was 
then added and mixed. The cells were lysed by boiling for 
10 min. After that the bacterial protein lysates were 
analyzed by sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE). The expression conditions 
were optimized with different temperature of 28°C, 33°C, 
37°C and different IPTG final concentration of 0.25 mM, 
0.5 mM, 1.0 mM, respectively. The recombinant His-
tagged EF-Tu protein was purified using a Ni–NTA 
column (Novagen, USA) and was then stored at -20°C 
until use. To test the immuno-reactivity of recombinant 
EF-Tu protein, Western blotting was performed using 
rabbit anti-M. ovipneumoniae polyclonal serum as 
primary antibody and goat anti-rabbit antibody conjugated 
with horseradish peroxidase (HRP) (Zhong Shan Golden 
Bridge Bio Co., Ltd., Beijing China) as secondary antibody. 
 
Immunization and sera collection: SPF BALB/c female 
mice (6-8 weeks old) (Lanzhou Institute of Biological 
Products, Lanzhou China) were randomly divided into 
five groups (five mice each group). Group 1, 2 and 3 were 
subcutaneously vaccinated with 40, 20, 10 µg of 
recombinant EF-Tu protein emulsified in Freund’s 
complete adjuvant (Sigma, Saint Louis USA) and boosted 
using emulsion with Freund’s incomplete adjuvant 
(Sigma, Saint Louis USA) at 15 and 30 days post first 
injection. Group 4 and 5, as control groups, received an 
equal volume of PBS and PBS+adjuvant, respectively. 
Blood samples were collected from the tail vein at 0, 15, 
30 and 45 days post inoculation (dpi), respectively. The 
sera were separated and stored at -20°C until use.    
 
Serum antibody detection: ELISA was employed to 
detect antigen-specific antibody in the sera of mice. 
Briefly, 96-well microtiter plates were coated overnight at 
4°C with 10 µg/ml recombinant EF-Tu protein. After 
washed with PBST (PBS with 0.05% Tween-20) for 4 
times, 50 µl of serum diluted at 1:10 in PBST was added 
and incubated at 37°C for 1 h, in triplicate. After wash, 
HRP-conjugated goat anti-mouse antibody (Beijing 
Solarbio Science & Technology Co, Ltd, Beijing, China) 
diluted in PBST at 1:800, was added and incubated at 
37°C for 1 h. The reactions were developed with 3, 3′, 5, 
5′-Tetramethylbenzidine (TMB) after the final washes 
steps. OD450 were measured in an ELISA Reader (Bio-rad, 
Philadelphia USA) 10 min later.  
Antibody titers were analyzed using One-way 
ANOVA algorithm of software SPSS version 19 (SPSS 
Co., Ltd., USA). The differences of data were considered 
significant if P≤0.05. 
 
RESULTS 
 
Characteristics of EF-Tu gene and its coding protein: 
The EF-Tu gene of M. ovipneumoniae strain GH3-3 was 
successfully amplified. Its sequence was consistent with 
that of strain SC01. The full-length of EF-Tu gene was 
1209 bp with a predicted molecular mass of 1098.5 kDa 
and with a (G+C) % content of 39.62%. Comparative 
analysis of EF-Tu DNA and amino acid sequence 
revealed that GH3-3 had 28.7 to 87.5% identity of DNA 
sequence and 6.8 to 97.8% identity of amino acid 
sequence with those of 11 other mycoplasmas, 
respectively. EF-Tu of M. hyopneumoniae was closest to 
that of GH3-3(87.5% of DNA and 97.8% of protein 
sequence identity). EF-Tu protein contains 402 amino 
acids with a predicted molecular weight of 43.863 kDa. 
Theoretical pI was 5.70, total number of negatively 
(Asp+Glu) or positively (Arg+Lys) charged residues is 61 
or 52. Formula was C1944H3131N531O596S12, total number of 
atoms was 6214. The estimated half-life was more than 10 
hours (E.coli,  in vivo). The instability index (II) wasPak Vet J, 2013, 33(4): 515-519. 
 
517
 
 
Fig. 1: Original and optimized DNA sequence of M. ovipneumoniae EF-Tu and its amino acid sequence. The bold and italic letters in the first line 
represent optimized nucleotides. The second line represents original sequences. The third line represents the amino acid sequence. 
 
computed to be 32.61, which classified the protein as 
stable. Secondary structure analysis indicated the protein 
contained a large number of α-helix and turns, but no 
trans-membrane region and signal peptide. Antigen 
epitopes prediction showed that the protein include 16 
antigenic epitopes, which would provide a theoretic clue 
for development of epitope-based vaccines against M. 
ovipneumoniae infection. 
 
Expression, purification and Western-blot analysis of 
EF-Tu:  The recombinant plasmid pET32a-EF-Tu was 
validated by digestion with restriction enzymes of Nco I 
and Xho I and sequencing of the insert. The recombinant 
EF-Tu of approximately 44 kDa was well expressed at 
37°C for 8 h with a concentration of 0.5 Mm IPTG. A 
high degree of purity of the recombinant protein was 
obtained after purification using Ni–NTA column. 
Western-blot suggested that the recombinant EF-Tu 
protein can react specifically with the serum against M. 
ovipneumoniae (Fig. 2). 
 
Serum antibody detection: The mean antibody titers to 
EF-Tu protein detected in mice sera from all groups by 
ELISA were shown in Fig. 3. In general, antibody levels Pak Vet J, 2013, 33(4): 515-519. 
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of mice from 3 immunized groups post vaccination were 
all significantly higher than that of pre-immune (P<0.05), 
that of PBS control group (P<0.05) and that of 
PBS+adjuvant control group (P<0.05). After the first 
immunization, all immunized mice produced considerable 
antibody responses (mean antibody titers) when compared 
to both controls (P<0.05), but there were no significant 
differences among the three immunized groups (P>0.05). 
The antibody titers of three immunized groups after the 
second immunization all appeared slight increase while 
there were no significant differences compared with first 
immunization (P>0.05), and no significant differences 
among immunized groups was observed. After the third 
immunization, antibody level of three immunized groups 
did not rise significantly (P>0.05, compared with the first 
and second immunization) and no significant differences 
among immunized groups were observed, but maintained 
at a steady level of antibodies which suggested that 
immunized mice with recombinant EF-Tu protein had 
arrived at a considerable and best antibody level after the 
second immunization. It was noted that the antibodies to 
recombinant EF-Tu were produced in mice from group of 
PBS+adjuvant after first injection, although there was no 
significant difference between the two control groups 
(P>0.05). 
 
DISCUSSION 
 
EF-Tu is one of the most important multifunctional 
proteins in organisms. A number of studies have 
demonstrated that EF-Tu is one of the most abundant 
bacterial proteins and conserved bacterial proteins and is a 
major component of the bacterial membrane cytoskeleton 
(Mayer, 2003; Jonak, 2007). EF-Tu constitutes 
approximately 10% of  total proteins in all bacterial 
investigated such as M. pneumonia (Regula et al., 2000). 
Recent evidences demonstrate that EF-Tu may play a 
previously under-appreciated role as a bacterial virulence 
factor and have a significant effect to facilitate invasion of 
host cells of M. pneumonia and Pseudomonas aeruginosa 
(Dallo et al., 2002; Kunert et al., 2007; Balasubramanian 
et al., 2008; Barel et al., 2008). Furthermore, some 
researches have identified EF-Tu as an immunodominant 
protein through immunoproteomic-based approaches for 
antigen discovery against other intracellular bacterial 
pathogens and mycoplasma (Bunk et al., 2008; Gupta et 
al., 2009; Nieves et al., 2010; Xu et al., 2012). EF-Tu of 
M. mycoides subsp. mycoides small-colony type 
(MmmSC) and M. hyopneumoniae strain 7448 had also 
been identified as a potential antigen (Alonso et al., 2002; 
Pinto et al., 2007). Taken together, all these achievement 
could provide support for our observations of 
immunogenic EF-Tu in the membrane of M. 
ovipneumoniae. In the present study, Western-blot 
showed that the recombinant EF-Tu of GH3-3 can be 
recognized by polyclonal serum of M. ovipneumoniae, it 
was proved to have a strong reactivity. By immunizing to 
mice the immunogenicity of EF-Tu was further 
confirmed. The results suggested that the EF-Tu is an 
antigenic protein of M. ovipneumoniae. However, the 
antibody responses among three groups of mice 
immunized with different doses of proteins have no 
significant     differences,    which    indicated    that     the 
 
 
Fig. 2: Western blotting of the recombinant EF-Tu protein using 
antiserum of M. ovipneumoniae. 1, protein marker; 2, purified 
recombinant EF-Tu. 
 
 
 
Fig. 3: Detection of antibody titers in srea from mice immunized with 
EF-Tu and PBS. Data points mean the average OD450 value. 
 
concentration of EF-Tu protein within the given range has 
less effect to antibody titers specific for EF-Tu antigen. 
On the other hand, although the antibody level of 
immunized mice did not increase significantly after the 
second and third immunization, a high level of antibody 
was maintained during the experiment when compared 
with the control group. The results suggested that EF-Tu 
has the ability to stimulate antibody production in mice.  
The PBS+adjuvant control group raises an antibody 
titer after first immunization, perhaps because Freund’s 
complete adjuvant contains Mycobacterium tuberculosis 
cell wall components. Based on the assumption, we 
conducted a homology comparison of EF-Tu amino acid 
sequence between M. tuberculosis and M. ovipneumoniae. 
The result showed that they share an identity of 67.5%, 
which may be a possible cause of producing antibody 
against EF-Tu of M. ovipneumoniae. It indicated that EF-
Tu cannot be a candidate for developing specific 
diagnostic methods depended on antibody detection. The 
antibody interference from Freund’s complete adjuvant 
should be considered in the similar experimental design.  
In some animal diseases caused by other 
mycoplasmas, immune protection has not been achieved 
when antibody responses can be obtained (Shahzad et al., 
2010). So the potential of EF-Tu of M. ovipneumoniae as 
a candidate vaccine protein should be further investigated, 
especially on cell-mediated immune responses of host.  Pak Vet J, 2013, 33(4): 515-519. 
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Conclusion: EF-Tu of M. ovipneumoniae is characterized 
and identified as an antigen. It can be further studied for a 
purpose of developing the molecular vaccine for M. 
ovipneumoniae infection.   
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